Handelsbanken Fonder Ab Care Dx, Inc. Transaction History

Handelsbanken Fonder Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$10.88 - $20.05 $250,240 - $461,150	23,000 New	23,000 $262,000
Q1 2022 May 11, 2022	SELL	$28.19 - $46.6 $315,728 - $521,920	-11,200 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$63.02 - $95.11 $138,644 - $209,242	2,200 Added 24.44%	11,200 $1.03 Million
Q1 2021 Apr 29, 2021	SELL	$57.62 - $95.6 $63,382 - $105,160	-1,100 Reduced 10.89%	9,000 $613,000
Q4 2020 Feb 11, 2021	BUY	$41.43 - $77.09 $116,004 - $215,852	2,800 Added 38.36%	10,100 $732,000
Q2 2020 Aug 13, 2020	BUY	$18.95 - $35.43 $138,335 - $258,639	7,300 New	7,300 $259,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.